4
Changes in Ownership
Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000131
Director sold 797 shares at $21.17 ($16,872)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Greenleaf Peter · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-02 | Sale : show line 1 in the form 10b5-1 | −797 | $21.17 | $16,872 | 23,087 | D |
| Open-market sales · 797 sh · avg $21.17 · $16,872 | ||||||
Loading xslF345X06/wk-form4_1791323650.xml…